Evidence map›Paper›PMID 30881378›Full record

ArticleFrontiers in genetics2019

Commentary: Identification of Mutation Regions on

Corina Anastasaki, Feng Gao, David H Gutmann

Abstract readComment
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. International journal of molecular sciences · 2021
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Corina AnastasakiDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
Feng GaoDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, United States.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, United States.

Funding

Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease HeterogeneityR35NS097211 · NINDS · WASHINGTON UNIVERSITY · PI GUTMANN, DAVID H · 2017 to 2024
$5.7M
Developing Human Induced Pluripotent Stem Cell Precision Oncology ModelsR50CA233164 · NCI · WASHINGTON UNIVERSITY · PI Corina Anastasaki · 2018 to 2026
$1.2M
NCI NIH HHS R50 CA233164NINDS NIH HHS R35 NS097211
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical risk assessmentgenotype-phenotype correlationsmutation locationneurofibromatosis type 1optic pathway glioma

Identifiers

PMID30881378
PMCPMC6405421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.